Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-08-07
2007-08-07
Andres, Janet L. (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
10524060
ABSTRACT:
A method of detecting Alzheimer's disease includes detecting a disruption or alteration in normal sub-cellular distribution of G-protein receptor kinases (GRKs), particularly GRK2 and GRK5. The disruption is caused by abnormal accumulation of soluble β-amyloid. The prevention or suppression of the disease progression at prodromal or early stages includes correction of GRK dysfunction.
REFERENCES:
patent: 6110693 (2000-08-01), Barak et al.
patent: WO 99/27944 (1999-06-01), None
Hardy et al. Science 2002. 297: 353-356.
Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes.Acta Neuropathol(Berl) 82, 239-59 (1991).
Saitoh, T., Horsburgh, K. & Masliah, E. Hyperactivation of signal transduction systems in Alzheimer's disease.Ann N Y Acad Sci695, 34-41 (1993).
Fowler, C.J., Cowburn, R.F., Garlind, A., Winblad, B. & O'Neill, C. Disturbances in signal transduction mechanisms in Alzheimer's disease.Mol Cell Biochem149-150, 287-92 (1995).
Joseph, J.A., Cutler, R. & Roth, G.S. Changes in G protein-mediated signal transduction in aging and Alzheimer's disease.Ann N Y Acad Sci695, 42-5 (1993).
Shimohama, S. et al. Aberrant phosphoinositide metabolism in Alzheimer's disease.Ann N Y Acad Sci695, 46-9 (1993).
Matsushima, H., Shimohama, S., Chachin, M., Taniguchi, T. & Kimura, J. Ca2+-independent and Ca2+-dependent protein kinase C changes in the brain of patients with Alzheimer's disease.J Neurochem67, 317-23 (1996).
Mattson, M.P. & Chan, S.L. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.J Mol Neurosci17, 205-24 (2001).
Fowler, C.J., Garlind, A., O'Neill, C. & Cowburn, R.F. Receptor-effector coupling dysfunctions in Alzheimer's disease.Ann N Y Acad Sci786, 294-304 (1996).
Hisatomi, O. et al. A novel subtype of G-protein-coupled receptor kinase, GRK7, in teleost cone photoreceptors.FEBS Lett424, 159-64. (1998).
Pitcher, J.A., Freedman, N.J. & Lefkowitz, R.J. G protein-coupled receptor kinases.Annu Rev Biochem67, 653-92 (1998).
Sallese, M. et al. Regulation of G protein-coupled receptor kinase subtypes by calcium sensor proteins.Biochim Biophys Acta1498, 112-21. (2000).
Bristow, M.R. et al. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.Circulation82, I12-25 (1990).
Ungerer, M., Kessebohm, K., Kronsbein, K., Lohse, M.J. & Richardt, G. Activation of beta-adrenergic receptor kinase during myocardial ischemia.Circ Res79, 455-60 (1996).
Gros, R., Benovic, J.L., Tan, C.M. & Feldman, R.D. G-protein-coupled receptor kinase activity is increased in hypertension.J Clin Invest99, 2087-93 (1997).
Premont, R.T., Inglese, J. & Lefkowitz, R.J. Protein kinases that phosphorylate activated G protein-coupled receptors.Faseb J9, 175-82 (1995).
Chen, J., Makino, C.L., Peachey, N.S., Baylor, D.A. & Simon, M.I. Mechanisms of rhodopsin inactivation in vivo as revealed by a COOH-terminal truncation mutant.Science267, 374-7 (1995).
Terwilliger, R.Z., Ortiz, J., Guitart, X. & Nestler, E.J. Chronic morphine administration increases beta-adrenergic receptor kinase (beta ARK) levels in the rat locus coeruleus.J Neurochem63, 1983-6 (1994).
Barak, L.S., Warabi, K., Feng, X., Caron, M.G. & Kwatra, M.M. Real-time visualization of the cellular redistribution of G protein-coupled receptor kinase 2 and beta-arrestin 2 during homologous desensitization of the substance P receptor.J Biol Chem274, 7565-9 (1999).
Harlan, J.E., Hajduk, P.J., Yoon, H.S. & Fesik, S.W. Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate.Nature371, 168-70 (1994).
DebBurman, S.K., Ptasienski, J., Benovic, J.L. & Hosey, M.M. G protein-coupled receptor kinase GRK2 is a phospholipid-dependent enzyme that can be conditionally activated by G protein betagamma subunits.J Biol Chem271, 22552-62 (1996).
Freeman, J.L., Pitcher, J.A., Li, X., Bennett, V. & Lefkowitz, R.J. alpha-Actinin is a potent regulator of G protein-coupled receptor kinase activity and substrate specificity in vitro.FEBS Lett473, 280-4 (2000).
Roth, G.S., Joseph, J.A. & Mason, R.P. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging.Trends Neurosci18, 203-6 (1995).
Price, D.L. et al. Sequestration of tubulin in neurons in Alzheimer's disease.Brain Res385, 305-10 (1986).
Wallace, M.A. Effects of Alzheimer's disease-related beta amyloid protein fragments on enzymes metabolizing phosphoinositides in brain.Biochim Biophys Acta1227, 183-7 (1994).
Mattson, M.P. et al. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.J Neurosci12, 376-89 (1992).
Chishti, M.A. et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of APP695.J Biol Chem15, 276(24):21562-70 (2001).
Schutzer, W.E., Reed, J.f., Bliziotes, M. & Mader, S.L. Upregulation of G protein-linked receptor kinases with advancing age in rat aorta.Am J Physiol Regul Integr Comp Physiol280, R897-903 (2001).
Griffin, W.S. et al. Glial-neuronal interactions in Alzheimer's disease: the potential role of a ‘cytokine cycle’ in disease progression.Brain Pathol8, 65-72 (1998).
Suo, Z. et al. Participation of protease-activated receptor-1 in thrombin-induced microglial activation.J Neurochem80, 655-66 (2002).
Crawford, F. et al. Alzheimer's beta-amyloid vasoactivity: identification of a novel beta- amyloid conformational intermediate.FEBS Lett436, 445-8 (1998).
Tiruppathi, C. et al. G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells.Proc Natl Acad Sci U S A97, 7440-5 (2000).
Shapiro, M.J., Weiss, E.J., Faruqi, T.R. & Coughlin, S.R. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin.J Biol Chem275, 25216-21. (2000).
Noda, M., Nakanishi, H., Nabekura, J. & Akaike, N. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia.J Neurosci20, 251-8 (2000).
Hajjar, A.M., Ernst, R.K., Tsai, J.H., Wilson, C.B. & Miller, S.I. Human Toll-like receptor 4 recognized host-specific LPS modifications.Nat Immunol3, 354-9 (2002).
Stanciu, M. et al. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures.J Biol Chem275, 12200-6 (2000).
Iversen, L.L., Mortishire-Smith, R.J., Pollack, S.J. & Shearman, M.S. The toxicity in vitro of beta-amyloid protein.Biochem J311, 1-16 (1995).
Meda, L. et al. Activation of microglial cells by beta-amyloid protein and interferon- gamma.Nature374, 647-50 (1995).
Lue, L.F. et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.Am J Pathol155(3):853-62 (1999).
Sigurdsson, E.M., Scholtzova, H., Mehta, P.D., Frangione, B. & Wisniewski, T. Immunization with a nontoxic
onfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice.Am J Pathol159, 439-47. (2001).
Lewis, J. et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.Science293, 1487-91 (2001).
Sandhu, F.A. et al. NMDA and AMPA receptors in transgenic mice expressing human beta- amyloid protein.J Neurochem61, 2286-9. (1993).
Smith, D.H. et al. Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein.Am J Pathol153, 1005-10 (1998).
Aragay, A.M. et al. Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2.Proc Natl Acad Sci U S A95, 2985-90 (1998).
Crawford, F., Suo, Z., Fang, C. & Mullan, M. Characteristics of the in vitro vasoactivity of beta-amyloid peptides.Exp Neurol150, 159-68 (1998).
Suo, Z. et al. Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo.Neurosci Lett257, 77-80 (1998).
Federal Interagency Forum on Aging-Related Statistics. 2000. O
Festoff Barry W.
Suo Zhiming
Andres Janet L.
Dinesh Agarwal, P.C.
United States of America Department of Veterans Affairs
Wang Chang-Yu
LandOfFree
Method of detecting and preventing Alzheimer's disease,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of detecting and preventing Alzheimer's disease,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of detecting and preventing Alzheimer's disease,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3838398